Corleen M. Roche
2021
In 2021, Corleen M. Roche earned a total compensation of $3.1M as Chief Financial Officer at Immunome.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $89,775 |
| Option Awards | $2,670,236 |
| Salary | $282,051 |
| Other | $3,905 |
| Total | $3,095,967 |
Roche received $2.7M in option awards, accounting for 86% of the total pay in 2021.
Roche also received $50K in bonus, $89.8K in non-equity incentive plan, $282.1K in salary and $3.9K in other compensation.
Rankings
In 2021, Corleen M. Roche's compensation ranked 4,306th out of 12,415 executives tracked by ExecPay. In other words, Roche earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,306 out of 12,415 | 65th |
Division Manufacturing | 1,779 out of 5,508 | 68th |
Major group Chemicals And Allied Products | 746 out of 2,378 | 69th |
Industry group Drugs | 666 out of 2,099 | 68th |
Industry Pharmaceutical Preparations | 473 out of 1,549 | 70th |
Source: SEC filing on April 20, 2023.
Roche's colleagues
We found two more compensation records of executives who worked with Corleen M. Roche at Immunome in 2021.